Evidence lags behind excitement over blood plasma as a coronavirus treatment

Heidi Ledford

Nature, 2020, vol. 584, issue 7822, 505-505

Abstract: Researchers call for more rigorous clinical trials as rumours abound that US regulators are considering widening access to the potential therapy.

Keywords: Medical research; Immunology; Infection; SARS-CoV-2 (search for similar items in EconPapers)
Date: 2020
References: Add references at CitEc
Citations:

Downloads: (external link)
https://www.nature.com/articles/d41586-020-02324-2 Abstract (text/html)
Access to the full text of the articles in this series is restricted.

Related works:
This item may be available elsewhere in EconPapers: Search for items with the same title.

Export reference: BibTeX RIS (EndNote, ProCite, RefMan) HTML/Text

Persistent link: https://EconPapers.repec.org/RePEc:nat:nature:v:584:y:2020:i:7822:d:10.1038_d41586-020-02324-2

Ordering information: This journal article can be ordered from
https://www.nature.com/

DOI: 10.1038/d41586-020-02324-2

Access Statistics for this article

Nature is currently edited by Magdalena Skipper

More articles in Nature from Nature
Bibliographic data for series maintained by Sonal Shukla () and Springer Nature Abstracting and Indexing ().